Small cell lung cancer metabolome (part II)
Ontology highlight
ABSTRACT: In addition to the generation and analysis of metabolomics data on cell lines, samples of normal lung tissue, adenocarcinoma lung tissue and small cell lung carcinoma tissue (seven samples/group) were processed and evaluated metabolite profile differences under the scope of the pilot and feasibility study. These data can be correlated to the metabolite profiles defined in the SCLC and NSCLC cell lines and integrated with the ABPP-determined metabolic kinases to identify distinct metabolic signatures or biomarkers (?oncometabolites?) that distinguish small cell lung cancer from non-small cell lung cancer.
INSTRUMENT(S): QTOF
ORGANISM(S): Human Homo Sapiens
TISSUE(S): Lung
DISEASE(S): Cancer
SUBMITTER: Susan Sumner
PROVIDER: ST000220 | MetabolomicsWorkbench | Fri Jun 26 00:00:00 BST 2015
REPOSITORIES: MetabolomicsWorkbench
ACCESS DATA